In a heated exchange over the role of technology in healthcare, Palantir Technologies is under fire from UK lawmakers regarding its handling of sensitive data within NHS contracts. Following guidance issued to NHS trusts mandating the use of Palantir’s core products, the company is defending its position amid growing public and political backlash.
Growing Concerns Over Data Security
The British Medical Journal recently reported that every NHS trust in England is expected to implement Palantir’s data solutions starting this month. This directive has sparked significant unease among politicians and the public, with Labour MP Emily Darlington labelling the involvement of a “foreign tech company” in patient data management as a “major security risk.” The Liberal Democrats have echoed these sentiments, asserting that Palantir should not be part of the UK’s national security infrastructure. Green Party leader Zack Polanski has gone as far as to describe the firm as a “military surveillance company,” fuelling concerns about the implications of its services in the NHS.
Adding to the chorus of criticism, Conservative MP Wendy Morton has called for a stringent review of Palantir’s capacity to safeguard NHS data. This scrutiny comes in light of Palantir securing a £300 million contract with NHS England for its Foundry federated data platform, which aims to integrate disparate databases across the health service. The contract is set for renewal early next year, putting additional pressure on the company to demonstrate its value and reliability.
The Benefits of Integration
Palantir contends that its software addresses critical challenges within the NHS by linking previously isolated databases, which has long been a hurdle for healthcare providers. The integration of data from various sectors—including GP practices, clinics, and hospitals—aims to enhance operational efficiency by streamlining patient information. Louis Mosley, Palantir UK’s executive vice-chair, expressed confidence in the company’s contributions during a recent appearance on BBC’s Politics Live.
“We’re tackling the issues of disconnected systems that plague the NHS,” Mosley stated. “Joining up that information is our mission, and we believe it is essential for improving patient care.” He further insisted that the company has no interest in accessing patient data, emphasising that such information remains protected under NHS ownership, just like data handled by everyday software applications such as Microsoft Excel.
Political Leaders Split on the Issue
Support for Palantir’s involvement in the NHS is not universal among MPs. Labour’s Alex McIntyre, a member of the Commons Health and Social Care Select Committee, defended the contract, asserting that strict measures are in place to ensure NHS data remains secure and within UK jurisdiction. “We have red lines here; the data must stay in the UK, and it must be NHS-owned,” he affirmed.
Conversely, Darlington has raised serious concerns regarding Palantir’s reputation, highlighting its historical funding ties to the CIA and contracts with the Israeli Defence Forces. She pointed out the incumbent risks of entrusting a company whose CEO has previously dismissed the NHS as a “delusion.” “It feels quite risky to hand over one of our most valuable resources when there are alternatives available,” she added.
Liberal Democrat leader Sir Ed Davey has called on Health Secretary Wes Streeting to cut ties with Palantir, insisting, “Donald Trump’s favourite tech giant shouldn’t be allowed anywhere near Brits’ private health data.” With alternatives available, many argue that British tech firms could provide safer options for the NHS.
Palantir Responds to Criticism
In light of the mounting scrutiny, Mosley welcomed the calls for transparency, stating, “I want us to be judged on the merits of the programme. We have robust answers to all concerns raised, and we believe our record speaks for itself.” He reassured the public that Palantir’s approach to data protection is rigorous and aligned with NHS requirements.
A spokesperson from the Department of Health and Social Care stated that the NHS Federated Data Platform is designed to enhance patient care while adhering to strict data security protocols. Each NHS trust maintains an independent instance of the platform, ensuring complete control over access to sensitive information.
Why it Matters
The debate surrounding Palantir’s role in the NHS brings to light broader concerns about data security and privacy in an increasingly digital healthcare landscape. As the NHS navigates the complexities of integrating technology to improve patient outcomes, the stakes are high. Ensuring that sensitive patient data remains secure while leveraging innovative solutions is crucial for maintaining public trust in the health service. The outcome of this scrutiny could set a precedent for how technology interacts with healthcare in the UK and beyond, influencing the future of patient data management.
